Enliven Therapeutics Inc (ELVN)

02:15 AM

What analyst consensus says on Enliven Therapeutics Inc. stock2025 Institutional Moves & Growth Focused Investment Plans - newser.com

02:15 AM

Nov 13, 2025

Is Enliven Therapeutics Inc. stock a contrarian buyJuly 2025 Weekly Recap & Reliable Volume Spike Trade Alerts - newser.com

Nov 13, 2025

Nov 13, 2025

Enliven Therapeutics Inc. stock daily chart insights2025 Momentum Check & Free Community Supported Trade Ideas - newser.com

Nov 13, 2025

Nov 13, 2025

Decoding Enliven Therapeutics Inc (ELVN): A Strategic SWOT Insig - GuruFocus

Nov 13, 2025

Nov 13, 2025

Enliven Therapeutics Reports Q3 2025 Financial Results - TipRanks

Nov 13, 2025

Nov 12, 2025

Published on: 2025-11-12 22:06:18 - newser.com

Nov 12, 2025

Nov 12, 2025

Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update - PR Newswire

Nov 12, 2025

Nov 12, 2025

Published on: 2025-11-12 18:07:48 - newser.com

Nov 12, 2025

Nov 12, 2025

Enliven Therapeutics Keeps Moving Forward As Losses Narrow And Cash Holds Strong - Finimize

Nov 12, 2025

Nov 12, 2025

Enliven Therapeutics Q3 net loss narrows - MarketScreener

Nov 12, 2025

Nov 12, 2025

Enliven Therapeutics Inc Stock Analysis and ForecastDay Trading Setups & Budget Friendly Growth - earlytimes.in

Nov 12, 2025

Nov 11, 2025

Published on: 2025-11-11 21:28:07 - newser.com

Nov 11, 2025

Nov 11, 2025

Enliven Therapeutics Advances Precision Oncology Research - Kalkine Media

Nov 11, 2025

Nov 10, 2025

Enliven Therapeutics (ELVN) Projected to Post Earnings on Wednesday - Defense World

Nov 10, 2025

Nov 10, 2025

Will ELVN-001 Enable Enliven Therapeutics To Capture A Share Of The CML Market? - RTTNews

Nov 10, 2025

Nov 10, 2025

Published on: 2025-11-10 05:45:09 - newser.com

Nov 10, 2025

Nov 06, 2025

Real time breakdown of Enliven Therapeutics Inc. stock performanceJuly 2025 Selloffs & Smart Investment Allocation Insights - newser.com

Nov 06, 2025

Nov 06, 2025

Using data filters to optimize entry into Enliven Therapeutics Inc.Breakout Watch & Daily Stock Trend Watchlist - newser.com

Nov 06, 2025

Nov 06, 2025

Will Enliven Therapeutics Inc. stock continue dividend increasesJuly 2025 Drop Watch & Weekly Momentum Picks - Fundação Cultural do Pará

Nov 06, 2025

Nov 06, 2025

Can Enliven Therapeutics Inc. stock deliver strong Q4 earningsJobs Report & Free AI Powered Buy and Sell Recommendations - newser.com

Nov 06, 2025

Nov 06, 2025

Is Enliven Therapeutics Inc. stock attractive for retirement portfoliosMarket Performance Summary & Real-Time Chart Pattern Alerts - fcp.pa.gov.br

Nov 06, 2025

Nov 06, 2025

Head-To-Head Comparison: Enliven Therapeutics (NASDAQ:ELVN) vs. NLS Pharmaceutics (NASDAQ:NCEL) - Defense World

Nov 06, 2025

Nov 06, 2025

Is Enliven Therapeutics Inc. stock positioned well for digital economyQuarterly Profit Review & Technical Pattern Recognition Alerts - newser.com

Nov 06, 2025

Nov 05, 2025

Enliven Therapeutics, Inc. (ELVN) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Nov 05, 2025

Nov 05, 2025

Published on: 2025-11-05 22:17:31 - newser.com

Nov 05, 2025

Nov 05, 2025

Is Enliven Therapeutics Inc. stock cheap compared to fundamentalsDollar Strength & Consistent Growth Equity Picks - newser.com

Nov 05, 2025

Nov 05, 2025

Published on: 2025-11-05 21:38:45 - newser.com

Nov 05, 2025

Nov 05, 2025

Enliven Therapeutics Inc. recovery potential after sell offJuly 2025 Big Picture & AI Optimized Trade Strategies - newser.com

Nov 05, 2025

Nov 05, 2025

(ELVN) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com

Nov 05, 2025

Nov 05, 2025

Stocks of Enliven Therapeutics Inc (ELVN) are poised to climb above their peers - setenews.com

Nov 05, 2025

Nov 04, 2025

Enliven Therapeutics (NASDAQ:ELVN) Stock Price Down 12.3%Here's What Happened - MarketBeat

Nov 04, 2025

Nov 04, 2025

Is Enliven Therapeutics Inc. stock a buy for dividend growthQuarterly Portfolio Summary & Long-Term Growth Plans - Fundação Cultural do Pará

Nov 04, 2025

Nov 03, 2025

Fed Watch: Is Enliven Therapeutics Inc. stock positioned well for digital economyQuarterly Portfolio Review & Risk Managed Investment Entry Signals - Fundação Cultural do Pará

Nov 03, 2025

Nov 03, 2025

Enliven Therapeutics showcases promising results for ELVN-001 in CML trial - Traders Union

Nov 03, 2025

Nov 03, 2025

Enliven (NASDAQ: ELVN) presents ELVN-001 CML data at ASH 2025 with >1 log transcript declines - Stock Titan

Nov 03, 2025